EMPACT syndrome

JDDG - Journal of the German Society of Dermatology

Volumn 3, Issue 1, 2005, Pages 39-43

  Wöhrl, Stefan ^a,c   Loewe, Robert ^a   Pickl, Winfried F ^b   Stingl, Georg ^a   Wagner, Stephan N ^a  

^a Universitatsklinik fur Dermatologie   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Anticonvulsant hypersensitivity; Drug hypersensitivity; EMPACT; Phenytoin; Seizure prophylaxis; Stevens Johnson Syndrome; Toxic epidermal necrolysis

Indexed keywords

ANALGESIC AGENT; CORTICOSTEROID; IMMUNOGLOBULIN; PHENYTOIN;

ADULT; ARTICLE; BRAIN METASTASIS; BRAIN RADIATION; CANCER RADIOTHERAPY; CASE REPORT; CHEMOPROPHYLAXIS; CORTICOSTEROID THERAPY; DRUG HYPERSENSITIVITY; DRUG MEGADOSE; DRUG WITHDRAWAL; EMPACT SYNDROME; ERYTHEMA MULTIFORME; FACE DISORDER; FEMALE; HUMAN; LOCAL THERAPY; LUNG CARCINOMA; PATCH TEST; POOR GENERAL CONDITION; RADIATION FIELD; RADIATION INJURY; RASH; SEIZURE; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS;

ADRENAL CORTEX HORMONES; ANTICONVULSANTS; BRAIN NEOPLASMS; BRONCHIAL NEOPLASMS; DRUG ERUPTIONS; EPIDERMAL NECROLYSIS, TOXIC; ERYTHEMA MULTIFORME; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MIDDLE AGED; PHENYTOIN; SEIZURES; SKIN TESTS; STEVENS-JOHNSON SYNDROME; SYNDROME; TIME FACTORS;

EID: 12944302577     PISSN: 16100379     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1439-0353.2005.04737.x     Document Type: Article

References (19)

1. Rapp RP, Norton JA, Young B, Tibbs PA. Cutaneous reactions in head-injured patients receiving phenytoin for seizure prophylaxis. Neurosurgery 1983; 13: 272-275.
2. Delattre JY, Safai B, Posner JB. Erythema multiforme and Stevens-Johnson syndrome in patients receiving cranial irradiation and phenytoin. Neurology 1988; 38(2): 194-198.
3. Ahmed I, Reichenberg J, Lucas A, Shehan JM. Erythema multiforme associated with phenytoin and cranial radiation therapy: a report of three patients and review of the literature. Int J Dermatol 2004; 43: 67-73.
4. Roujeau JC. The spectrum of Stevens-Johnson syndrome and toxic epidermal necrolysis: a clinical classification. J Invest Dermatol 1994; 102: 28S-30S.
5. Aberer W, Bircher A, Romano A, Bianca M, Campi P, Fernandez J, et al. Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations. Allergy 2003; 58: 854-863.
6. Bocquet H, Bagot M, Roujeau JC. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS). Semin Cutan Med Surg 1996; 15: 250-257.
7. Pichler WJ, Tilch J. The lymphocyte transformation test in the diagnosis of drug hypersensitivity. Allergy 2004; 59: 809-820.
8. Mauri-Hellweg D, Bettens F, Mauri D, Brander C, Hunziker T, Pichler WJ. Activation of drug-specific CD4+ and CD8+ T cells in individuals allergic to sulfonamides, phenytoin, and carbamazepine. J Immunol 1995; 155: 462-472.
9. Gleichmann H. Studies on the mechanism of drug sensitization: T-cell-dependent popliteal lymph node reaction to diphenylhydantoin. Clin Immunol Immunopathol 1981; 18: 203-211.
10. Basaran N, Hincal F, Kansu E, Ciger A. Humoral and cellular immune parameters in untreated and phenytoinor carbamazepine-treated epileptic patients. Int J Immunopharmacol 1994; 16: 1071-1077.
11. Dosch HM, Jason J, Gelfand EW. Transient antibody deficiency and abnormal T-suppressor cells induced by phenytoin. N Engl J Med 1982; 306: 406-409.
12. Pichler W, Yawalkar N, Schmid S, Helbling A. Pathogenesis of drug-induced exanthems. Allergy 2002; 57: 884-893.
13. Kim SH, Lim DJ, Chung YG, Cho TH, Lim SJ, Kim WJ, et al. Expression of TNF-alpha and TGF-beta 1 in the rat brain after a single high-dose irradiation. J Korean Med Sci 2002; 17: 242-248.
14. Gaber MW, Sabek OM, Fukatsu K, Wilcox HG, Kiani MF, Merchant TE. Differences in ICAM-1 and TNF-alpha expression between large single fraction and fractionated irradiation in mouse brain. Int J Radiat Biol 2003; 79: 359-366.
15. Chung WH, Hung SI, Hong HS, Hsih MS, Yang LC, Ho HC, et al. Medical genetics: a marker for Stevens-Johnson syndrome. Nature 2004; 428: 486.
16. Soga Y, Nishimura F, Ohtsuka Y, Araki H, Iwamoto Y, Naruishi H, et al. CYP2C polymorphisms, phenytoin metabolism and gingival overgrowth in epileptic subjects. Life Sci 2004; 74: 827-834.
17. Sharma VK, Vatve M, Sawhney IM, Kumar B. Clinical spectrum of drug rashes due to antiepileptics. J Assoc Physicians India 1998; 46: 595-597.
18. Cohen N, Strauss G, Lew R, Silver D, Recht L. Should prophylactic anticonvulsants be administered to patients with newly-diagnosed cerebral metastases? A retrospective analysis. J Clin Oncol 1988; 6: 1621-1624.
19. Misra UK, Kalita J, Rathore C. Phenytoin and carbamazepine cross reactivity: report of a case and review of literature. Postgrad Med J 2003; 79: 703-704.